SOUMYAJIT ROY
@SouMyajiT_RO
Human Physician #RadOnc #Researcher proud #IMG @RushCancer resident. Editor @ASTRO_org @FrontOncology MSc Biostat+Epidem @EdinburghUni #RStats #PCSM enthusiast
ID:4873918177
07-02-2016 13:47:30
982 Tweets
499 Followers
399 Following
Exciting #RadOnc faculty opportunity for HN/Thoracic cancers Rush University Cancer Center RUSH Rush Radiation Oncology Residency Rush Otorhinolaryngology Head and Neck Surgery ASTRO ARRO
Apply here: joinrush.org/jobs/307706/?o…
Patients visiting AIIMS, New Delhi for various ailments are seen at AIIMS 24x7 without any registration charges. All investigations charged less than 300 INR have been exempted so that Health care is #PocketFriendly
#PMJAY #AyushmanBharat
#SwasthBharat
This is really encouraging. Congratulations May F. Elbanna. I am sure you will do wonders. Thank you very much ASTRO ARRO. Looking forward to see how #IMGs are integrated under the umbrella of #DEI . IMG Oncologists
Latest paper from Dr. Andy Wang 🇺🇦 #NikhilaSultanpuram UTSW Radiation Oncology UTSW Simmons Cancer Center on engineered metastases as cancer vaccine with higher immune responsiveness to cancer immunotherapy. Dr. Sultanpuram is one to watch - interviewing for radiation oncology residency this season!
Survival in M1 de novo castration sensitive PCa. Try the new nomogram on: rdcu.be/cWUaX
Amar Kishan Daniel E Spratt SOUMYAJIT ROY Christopher Wallis Tanya Dorff
#pcsm #metastasis #ProstateCancer
It’s #RTT lecture week and we’re learning about set-up and alignment. Always humbled to further understand what we put our patients through!
Rush Radiation Oncology Residency Rush University Cancer Center #radiationoncology #radonc #radiationtherapist
Breaking news: Phase 3 randomized TALAPRO-2 trial of Enza + Talazoparib vs. Enza meets primary endpoint in the 1st line mCRPC #ProstateCancer in both HRR+ and HRR- patients (study design👇).Press release 👉 bit.ly/3SSjJAp OncoAlert UroToday.com GU Cancer Research Program @HuntsmanCancer PCF Science
Congrats to our superstar PGY3, Leah D'Souza, MD, MSc on being awarded 1 of only 4 ACRO Luther Brady Educational Grants issued! #RadOnc ACROresident ACRO - American College of Radiation Oncology Gaurav Marwaha Nikhil Joshi Rush University Cancer Center Rush University
The ASCENDE-SBRT trial. HDR brachy+23# EBRT vs. 5# SBRT for unfavourable prostate ca. Amazing CCTG study led by Dr. Andrew Loblaw Sunnybrook Health Sciences Centre.
Can non-invasive, cheaper high precision SBRT be used to avoid invasive brachy + GA & multiple visits ?
Shift that paradigm!
International medical graduates face many barriers - #bias is unfortunately one
Our research 👇🏽 - let's use this to improve things for our #IMG trainees!
ASCO ASH Penn Cancer Innovation #MedTwitter #MedEd
#DiversityandInclusion
ascopubs.org/doi/full/10.12…
Important/timely paper in Journal of Clinical Oncology Oncology Practice calling out challenges #IMGs face during their road to Academia. Kudos to the team (including Ariela Marshall MD Abramson Cancer Ctr. & Alfred Lee Yale Cancer Center) IMG Oncologists OncoAlert Oncology Brothers
A must read!
ascopubs.org/doi/abs/10.120…
Scope day! Nikhil Joshi taking our residents on a deep dive through the head and neck of our brave PGY-3, SOUMYAJIT ROY #Didactics Rush University Cancer Center RUSH Gaurav Marwaha